Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (361-370 of 397) with videos related to

Pageof 40
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 3, 2021
Assessing the Potential Impact of Disruptions Due to COVID-19 on HIV Among Key and Lower-Risk Populations in the Largest Cities of Cameroon and BeninRomain Silhol, Lily Geidelberg, Kate M Mitchell, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2023
Global reporting of progress towards elimination of hepatitis B and hepatitis CFuqiang Cui, Sarah Blach, Casimir Manzengo Mingiedi, et al.
BMJ Open|November 19, 2020
Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C)Delphine Rapoud, Catherine Quillet, Khue Pham Minh, et al.
BMJ Open|March 24, 2026
Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocolBridget Louise Draper, Mia Flynn, Sophia Schroeder, et al.
Lancet (London, England)|March 30, 2016
Public health and international drug policyJoanne Csete, Adeeba Kamarulzaman, Michel Kazatchkine, et al.
Journal of the International AIDS Society|July 11, 2019
Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration studyAminata Mboup, Luc Béhanzin, Fernand A Guédou, et al.
Journal of Hepatology|October 30, 2017
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in EuropeHannah Fraser, Natasha K Martin, Henrikki Brummer-Korvenkontio, et al.
BMC Infectious Diseases|November 26, 2025
Risk prediction models for targeted testing of HIV, hepatitis B and hepatitis C: a systematic review and meta-analysisWerner Leber, Hamzah Z Farooq, Jasmina Panovska-Griffiths, et al.
The Lancet. HIV|November 23, 2025
Identifying priority populations for HIV interventions using acquisition and transmission indicators: a combined analysis of 15 mathematical models from ten African countriesRomain Silhol, Ross D Booton, Kate M Mitchell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2020
Mathematical Model Impact Analysis of a Real-Life Pre-exposure Prophylaxis and Treatment-As-Prevention Study Among Female Sex Workers in Cotonou, BeninLily Geidelberg, Kate M Mitchell, Michel Alary, et al.
Pageof 40

Showing results (361-370 of 397) with videos related to

Sort By:
Pageof 40
Journal of Acquired Immune Deficiency Syndromes (1999)|March 3, 2021
Assessing the Potential Impact of Disruptions Due to COVID-19 on HIV Among Key and Lower-Risk Populations in the Largest Cities of Cameroon and BeninRomain Silhol, Lily Geidelberg, Kate M Mitchell, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2023
Global reporting of progress towards elimination of hepatitis B and hepatitis CFuqiang Cui, Sarah Blach, Casimir Manzengo Mingiedi, et al.
BMJ Open|November 19, 2020
Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C)Delphine Rapoud, Catherine Quillet, Khue Pham Minh, et al.
BMJ Open|March 24, 2026
Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocolBridget Louise Draper, Mia Flynn, Sophia Schroeder, et al.
Lancet (London, England)|March 30, 2016
Public health and international drug policyJoanne Csete, Adeeba Kamarulzaman, Michel Kazatchkine, et al.
Journal of the International AIDS Society|July 11, 2019
Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration studyAminata Mboup, Luc Béhanzin, Fernand A Guédou, et al.
Journal of Hepatology|October 30, 2017
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in EuropeHannah Fraser, Natasha K Martin, Henrikki Brummer-Korvenkontio, et al.
BMC Infectious Diseases|November 26, 2025
Risk prediction models for targeted testing of HIV, hepatitis B and hepatitis C: a systematic review and meta-analysisWerner Leber, Hamzah Z Farooq, Jasmina Panovska-Griffiths, et al.
The Lancet. HIV|November 23, 2025
Identifying priority populations for HIV interventions using acquisition and transmission indicators: a combined analysis of 15 mathematical models from ten African countriesRomain Silhol, Ross D Booton, Kate M Mitchell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2020
Mathematical Model Impact Analysis of a Real-Life Pre-exposure Prophylaxis and Treatment-As-Prevention Study Among Female Sex Workers in Cotonou, BeninLily Geidelberg, Kate M Mitchell, Michel Alary, et al.
Pageof 40